Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Dianne Madelyn Finkelstein, PH.D.

TitleProfessor in the Department of Biostatistics
InstitutionHarvard School of Public Health
DepartmentBiostatistics
AddressMassachusetts General Hospital
Biostatistics Center, Ste 560
50 Staniford Street
Boston MA 02114
Phone617/726-5970
Other Positions
TitleProfessor of Medicine
InstitutionMassachusetts General Hospital
DepartmentMedicine
DivisionHematology/Oncology


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Goss PE, Smith IE, O'Shaughnessy J, Ejlertsen B, Kaufmann M, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Chavarri-Guerra Y, Aktan G, Rappold E, Williams LS, Finkelstein DM. Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial. Lancet Oncol. 2013 Jan; 14(1):88-96.
    View in: PubMed
  2. Chávarri-Guerra Y, Villarreal-Garza C, Liedke PE, Knaul F, Mohar A, Finkelstein DM, Goss PE. Breast cancer in Mexico: a growing challenge to health and the health system. Lancet Oncol. 2012 Aug; 13(8):e335-43.
    View in: PubMed
  3. Nehra D, Oyarvide VM, Mino-Kenudson M, Thayer SP, Ferrone CR, Wargo JA, Muzikansky A, Finkelstein D, Warshaw AL, Castillo CF. Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter? Pancreatology. 2012 Jul-Aug; 12(4):358-63.
    View in: PubMed
  4. Lee BL, Liedke PE, Barrios CH, Simon SD, Finkelstein DM, Goss PE. Breast cancer in Brazil: present status and future goals. Lancet Oncol. 2012 Mar; 13(3):e95-e102.
    View in: PubMed
  5. Lowery JT, Marcus A, Kinney A, Bowen D, Finkelstein DM, Horick N, Garrett K, Haile R, Sandler R, Ahnen DJ. The Family Health Promotion Project (FHPP): design and baseline data from a randomized trial to increase colonoscopy screening in high risk families. Contemp Clin Trials. 2012 Mar; 33(2):426-35.
    View in: PubMed
  6. Morse RE, Nadkarni P, Schoenfeld DA, Finkelstein DM. Web-browser encryption of personal health information. BMC Med Inform Decis Mak. 2011; 11:70.
    View in: PubMed
  7. Skates SJ, Mai P, Horick NK, Piedmonte M, Drescher CW, Isaacs C, Armstrong DK, Buys SS, Rodriguez GC, Horowitz IR, Berchuck A, Daly MB, Domchek S, Cohn DE, Van Le L, Schorge JO, Newland W, Davidson SA, Barnes M, Brewster W, Azodi M, Nerenstone S, Kauff ND, Fabian CJ, Sluss PM, Nayfield SG, Kasten CH, Finkelstein DM, Greene MH, Lu K. Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status. Cancer Prev Res (Phila). 2011 Sep; 4(9):1401-8.
    View in: PubMed
  8. Ziogas A, Horick NK, Kinney AY, Lowery JT, Domchek SM, Isaacs C, Griffin CA, Moorman PG, Edwards KL, Hill DA, Berg JS, Tomlinson GE, Anton-Culver H, Strong LC, Kasten CH, Finkelstein DM, Plon SE. Clinically relevant changes in family history of cancer over time. JAMA. 2011 Jul 13; 306(2):172-8.
    View in: PubMed
  9. Finkelstein DM, Schoenfeld DA. Correcting for discretionary treatment crossover in an analysis of survival in the Breast International Group BIG 1-98 trial by using the inverse probability of censoring weighted method. J Clin Oncol. 2011 Mar 20; 29(9):1093-5.
    View in: PubMed
  10. Schoenfeld DA, Rajicic N, Ficociello LH, Finkelstein DM. A test for the relationship between a time-varying marker and both recovery and progression with missing data. Stat Med. 2011 Mar 30; 30(7):718-24.
    View in: PubMed
  11. Rajicic N, Cuschieri J, Finkelstein DM, Miller-Graziano CL, Hayden D, Moldawer LL, Moore E, O'Keefe G, Pelik K, Warren HS, Schoenfeld DA. Identification and interpretation of longitudinal gene expression changes in trauma. PLoS One. 2010; 5(12):e14380.
    View in: PubMed
  12. Rizvi I, Celli JP, Evans CL, Abu-Yousif AO, Muzikansky A, Pogue BW, Finkelstein D, Hasan T. Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. Cancer Res. 2010 Nov 15; 70(22):9319-28.
    View in: PubMed
  13. Finkelstein DM, Wang R, Ficociello LH, Schoenfeld DA. A score test for association of a longitudinal marker and an event with missing data. Biometrics. 2010 Sep; 66(3):726-32.
    View in: PubMed
  14. Moorman PG, Iversen ES, Marcom PK, Marks JR, Wang F, Lee E, Ursin G, Rebbeck TR, Domchek SM, Arun B, Susswein L, Isaacs C, Garber JE, Visvanathan K, Griffin CA, Sutphen R, Brzosowicz J, Gruber S, Finkelstein DM, Schildkraut JM. Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis. Breast Cancer Res Treat. 2010 Nov; 124(2):441-51.
    View in: PubMed
  15. Nichols AC, Finkelstein DM, Faquin WC, Westra WH, Mroz EA, Kneuertz P, Begum S, Michaud WA, Busse PM, Clark JR, Rocco JW. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer. Clin Cancer Res. 2010 Apr 1; 16(7):2138-46.
    View in: PubMed
  16. Crippa S, Fernández-Del Castillo C, Salvia R, Finkelstein D, Bassi C, Domínguez I, Muzikansky A, Thayer SP, Falconi M, Mino-Kenudson M, Capelli P, Lauwers GY, Partelli S, Pederzoli P, Warshaw AL. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol. 2010 Feb; 8(2):213-9.
    View in: PubMed
  17. Rajicic N, Finkelstein DM, Schoenfeld DA. Analysis of the relationship between longitudinal gene expressions and ordered categorical event data. Stat Med. 2009 Sep 30; 28(22):2817-32.
    View in: PubMed
  18. Schoenfeld DA, Finkelstein DM. Bayesian design using adult data to augment pediatric trials. Clin Trials. 2009 Aug; 6(4):297-304.
    View in: PubMed
  19. Souglakos J, Philips J, Wang R, Marwah S, Silver M, Tzardi M, Silver J, Ogino S, Hooshmand S, Kwak E, Freed E, Meyerhardt JA, Saridaki Z, Georgoulias V, Finkelstein D, Fuchs CS, Kulke MH, Shivdasani RA. Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer. Br J Cancer. 2009 Aug 4; 101(3):465-72.
    View in: PubMed
  20. Neklason DW, Kerber RA, Nilson DB, Anton-Culver H, Schwartz AG, Griffin CA, Lowery JT, Schildkraut JM, Evans JP, Tomlinson GE, Strong LC, Miller AR, Stopfer JE, Finkelstein DM, Nadkarni PM, Kasten CH, Mineau GP, Burt RW. Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis. Cancer Res. 2008 Nov 1; 68(21):8993-7.
    View in: PubMed
  21. Matthews AG, Finkelstein DM, Betensky RA. Analysis of familial aggregation studies with complex ascertainment schemes. Stat Med. 2008 Oct 30; 27(24):5076-92.
    View in: PubMed
  22. Kerber RA, Amos CI, Yeap BY, Finkelstein DM, Thomas DC. Design considerations in a sib-pair study of linkage for susceptibility loci in cancer. BMC Med Genet. 2008; 9:64.
    View in: PubMed
  23. Bell DW, Brannigan BW, Matsuo K, Finkelstein DM, Sordella R, Settleman J, Mitsudomi T, Haber DA. Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms. Clin Cancer Res. 2008 Jul 1; 14(13):4079-84.
    View in: PubMed
  24. Alm El-Din MA, Hughes KS, Finkelstein DM, Betts KA, Yock TI, Tarbell NJ, Aisenberg AC, Taghian AG. Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter. Int J Radiat Oncol Biol Phys. 2009 Jan 1; 73(1):69-74.
    View in: PubMed
  25. Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, Lauwers GY, Kulu Y, Muzikansky A, Kuruppu D, Lanuti M, Goodwin JM, Azoulay D, Fuchs BC. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA. 2008 Jan 2; 299(1):53-60.
    View in: PubMed
  26. Parmigiani G, Chen S, Iversen ES, Friebel TM, Finkelstein DM, Anton-Culver H, Ziogas A, Weber BL, Eisen A, Malone KE, Daling JR, Hsu L, Ostrander EA, Peterson LE, Schildkraut JM, Isaacs C, Corio C, Leondaridis L, Tomlinson G, Amos CI, Strong LC, Berry DA, Weitzel JN, Sand S, Dutson D, Kerber R, Peshkin BN, Euhus DM. Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med. 2007 Oct 2; 147(7):441-50.
    View in: PubMed
  27. Zhang Z, Sun L, Sun J, Finkelstein DM. Regression analysis of failure time data with informative interval censoring. Stat Med. 2007 May 30; 26(12):2533-46.
    View in: PubMed
  28. Matthews AG, Finkelstein DM, Betensky RA. Multivariate logistic regression for familial aggregation in age at disease onset. Lifetime Data Anal. 2007 Jun; 13(2):191-209.
    View in: PubMed
  29. Stephen AE, Roth SI, Fardo DW, Finkelstein DM, Randolph GW, Gaz RD, Hodin RA. Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas. Arch Surg. 2007 Apr; 142(4):381-6.
    View in: PubMed
  30. Ficociello LH, Perkins BA, Silva KH, Finkelstein DM, Ignatowska-Switalska H, Gaciong Z, Cupples LA, Aschengrau A, Warram JH, Krolewski AS. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors. Clin J Am Soc Nephrol. 2007 May; 2(3):461-9.
    View in: PubMed
  31. Rajicic N, Finkelstein DM, Schoenfeld DA. Survival analysis of longitudinal microarrays. Bioinformatics. 2006 Nov 1; 22(21):2643-9.
    View in: PubMed
  32. Ferrone CR, Finkelstein DM, Thayer SP, Muzikansky A, Fernandez-delCastillo C, Warshaw AL. Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol. 2006 Jun 20; 24(18):2897-902.
    View in: PubMed
  33. Chen S, Iversen ES, Friebel T, Finkelstein D, Weber BL, Eisen A, Peterson LE, Schildkraut JM, Isaacs C, Peshkin BN, Corio C, Leondaridis L, Tomlinson G, Dutson D, Kerber R, Amos CI, Strong LC, Berry DA, Euhus DM, Parmigiani G. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol. 2006 Feb 20; 24(6):863-71.
    View in: PubMed
  34. Matthews AG, Betensky RA, Anton-Culver H, Bowen D, Griffin C, Isaacs C, Kasten C, Mineau G, Nayfield S, Schildkraut J, Strong L, Weber B, Finkelstein DM. Analysis of co-aggregation of cancer based on registry data. Community Genet. 2006; 9(2):87-92.
    View in: PubMed
  35. Amrein PC, Clark JR, Supko JG, Fabian RL, Wang CC, Colevas AD, Posner MR, Deschler DG, Rocco JW, Finkelstein DM, McIntyre JF. Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma. Cancer. 2005 Oct 1; 104(7):1418-27.
    View in: PubMed
  36. Tyminski E, Leroy S, Terada K, Finkelstein DM, Hyatt JL, Danks MK, Potter PM, Saeki Y, Chiocca EA. Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan. Cancer Res. 2005 Aug 1; 65(15):6850-7.
    View in: PubMed
  37. Nguyen PL, Chakravarti A, Finkelstein DM, Hochberg FH, Batchelor TT, Loeffler JS. Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. J Clin Oncol. 2005 Mar 1; 23(7):1507-13.
    View in: PubMed
  38. Ancukiewicz M, Finkelstein DM, Schoenfeld DA. Modelling the relationship between continuous covariates and clinical events using isotonic regression. Stat Med. 2003 Oct 30; 22(20):3151-9.
    View in: PubMed
  39. Finkelstein DM, Muzikansky A, Schoenfeld DA. Comparing survival of a sample to that of a standard population. J Natl Cancer Inst. 2003 Oct 1; 95(19):1434-9.
    View in: PubMed
  40. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. N Engl J Med. 2003 Jun 5; 348(23):2285-93.
    View in: PubMed
  41. Anton-Culver H, Ziogas A, Bowen D, Finkelstein D, Griffin C, Hanson J, Isaacs C, Kasten-Sportes C, Mineau G, Nadkarni P, Rimer B, Schildkraut J, Strong L, Weber B, Winn D, Hiatt R, Nayfield S. The Cancer Genetics Network: recruitment results and pilot studies. Community Genet. 2003; 6(3):171-7.
    View in: PubMed
  42. Pierie JP, Choudry U, Muzikansky A, Finkelstein DM, Ott MJ. Prognosis and management of extramammary Paget's disease and the association with secondary malignancies. J Am Coll Surg. 2003 Jan; 196(1):45-50.
    View in: PubMed
  43. Pauler DK, Finkelstein DM. Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcomes. Stat Med. 2002 Dec 30; 21(24):3897-911.
    View in: PubMed
  44. Ettinger DS, Finkelstein DM, Ritch PS, Lincoln ST, Blum RH. Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588). Lung Cancer. 2002 Sep; 37(3):311-8.
    View in: PubMed
  45. Finkelstein DM, Goggins WB, Schoenfeld DA. Analysis of failure time data with dependent interval censoring. Biometrics. 2002 Jun; 58(2):298-304.
    View in: PubMed
  46. Hodi FS, Soiffer RJ, Clark J, Finkelstein DM, Haluska FG. Phase II study of paclitaxel and carboplatin for malignant melanoma. Am J Clin Oncol. 2002 Jun; 25(3):283-6.
    View in: PubMed
  47. Betensky RA, Finkelstein DM. Testing for dependence between failure time and visit compliance with interval-censored data. Biometrics. 2002 Mar; 58(1):58-63.
    View in: PubMed
  48. Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ, Loeffler JS. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol. 2002 Feb 15; 20(4):1063-8.
    View in: PubMed
  49. DiRienzo AG, van Der Horst C, Finkelstein DM, Frame P, Bozzette SA, Tashima KT. Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection. AIDS Res Hum Retroviruses. 2002 Jan 20; 18(2):89-94.
    View in: PubMed
  50. Shannon KM, Lubratovich ML, Finkelstein DM, Smith BL, Powell SN, Seiden MV. Model-based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center. Cancer. 2002 Jan 15; 94(2):305-13.
    View in: PubMed
  51. McKee GT, Tambouret RH, Finkelstein D. A reliable method of demonstrating HER-2/neu, estrogen receptors, and progesterone receptors on routinely processed cytologic material. Appl Immunohistochem Mol Morphol. 2001 Dec; 9(4):352-7.
    View in: PubMed
  52. McKee GT, Tambouret RH, Finkelstein D. Fine-needle aspiration cytology of the breast: Invasive vs. in situ carcinoma. Diagn Cytopathol. 2001 Jul; 25(1):73-7.
    View in: PubMed
  53. Pai HH, Thornton A, Katznelson L, Finkelstein DM, Adams JA, Fullerton BC, Loeffler JS, Leibsch NJ, Klibanski A, Munzenrider JE. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2001 Mar 15; 49(4):1079-92.
    View in: PubMed
  54. Goggins WB, Finkelstein DM, Tsao H. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer. 2001 Feb 15; 91(4):874-80.
    View in: PubMed
  55. Breathnach OS, Kwiatkowski DJ, Finkelstein DM, Godleski J, Sugarbaker DJ, Johnson BE, Mentzer S. Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease. J Thorac Cardiovasc Surg. 2001 Jan; 121(1):42-7.
    View in: PubMed
  56. Wenkel E, Thornton AF, Finkelstein D, Adams J, Lyons S, De La Monte S, Ojeman RG, Munzenrider JE. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys. 2000 Dec 1; 48(5):1363-70.
    View in: PubMed
  57. Chaudhuri S, Cariappa A, Tang M, Bell D, Haber DA, Isselbacher KJ, Finkelstein D, Forcione D, Pillai S. Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles. Proc Natl Acad Sci U S A. 2000 Oct 10; 97(21):11451-4.
    View in: PubMed
  58. Robins JM, Finkelstein DM. Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics. 2000 Sep; 56(3):779-88.
    View in: PubMed
  59. Goggins WB, Finkelstein DM. A proportional hazards model for multivariate interval-censored failure time data. Biometrics. 2000 Sep; 56(3):940-3.
    View in: PubMed
  60. Tsao H, Zhang X, Kwitkiwski K, Finkelstein DM, Sober AJ, Haluska FG. Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma. Arch Dermatol. 2000 Sep; 136(9):1118-22.
    View in: PubMed
  61. Para MF, Finkelstein D, Becker S, Dohn M, Walawander A, Black JR. Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268. J Acquir Immune Defic Syndr. 2000 Aug 1; 24(4):337-43.
    View in: PubMed
  62. Domchek SM, Younger J, Finkelstein DM, Seiden MV. Predictors of skeletal complications in patients with metastatic breast carcinoma. Cancer. 2000 Jul 15; 89(2):363-8.
    View in: PubMed
  63. Harsh GR, Deisboeck TS, Louis DN, Hilton J, Colvin M, Silver JS, Qureshi NH, Kracher J, Finkelstein D, Chiocca EA, Hochberg FH. Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study. J Neurosurg. 2000 May; 92(5):804-11.
    View in: PubMed
  64. Chakravatri A, Zehr EM, Zietman AL, Shipley WU, Goggins WB, Finkelstein DM, Young RH, Chang EL, Wu CL. Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer-results from a pilot study. Urology. 2000 May; 55(5):635-8.
    View in: PubMed
  65. Aisenberg AC, Finkelstein DM. Second malignancies in Hodgkin's disease. J Clin Oncol. 2000 May; 18(10):2186-7.
    View in: PubMed
  66. Myojin M, Choi NC, Wright CD, Wain JC, Harris N, Hug EB, Mathisen DJ, Lynch T, Carey RW, Grossbard M, Finkelstein DM, Grillo HC. Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. Int J Radiat Oncol Biol Phys. 2000 Mar 1; 46(4):927-33.
    View in: PubMed
  67. Wolfe BE, Metzger ED, Levine JM, Finkelstein DM, Cooper TB, Jimerson DC. Serotonin function following remission from bulimia nervosa. Neuropsychopharmacology. 2000 Mar; 22(3):257-63.
    View in: PubMed
  68. Dubovy SR, Hairston RJ, Schatz H, Schachat AP, Bressler NM, Finkelstein D, Green WR. Adult-onset foveomacular pigment epithelial dystrophy: clinicopathologic correlation of three cases. Retina. 2000; 20(6):638-49.
    View in: PubMed
  69. Ryan DP, Lynch TJ, Grossbard ML, Seiden MV, Fuchs CS, Grenon N, Baccala P, Berg D, Finkelstein D, Mayer RJ, Clark JW. A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors. Cancer. 2000 Jan 1; 88(1):180-5.
    View in: PubMed
  70. Betensky RA, Finkelstein DM. A non-parametric maximum likelihood estimator for bivariate interval censored data. Stat Med. 1999 Nov 30; 18(22):3089-100.
    View in: PubMed
  71. Betensky RA, Finkelstein DM. An extension of Kendall's coefficient of concordance to bivariate interval censored data. Stat Med. 1999 Nov 30; 18(22):3101-9.
    View in: PubMed
  72. Goggins WB, Finkelstein DM, Zaslavsky AM. Applying the Cox proportional hazards model for analysis of latency data with interval censoring. Stat Med. 1999 Oct 30; 18(20):2737-47.
    View in: PubMed
  73. Colby C, McAfee S, Sackstein R, Finkelstein D, Fishman J, Spitzer T. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1999 Oct; 24(8):897-902.
    View in: PubMed
  74. Terahara A, Niemierko A, Goitein M, Finkelstein D, Hug E, Liebsch N, O'Farrell D, Lyons S, Munzenrider J. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. Int J Radiat Oncol Biol Phys. 1999 Sep 1; 45(2):351-8.
    View in: PubMed
  75. Ikeda K, Ichikawa T, Wakimoto H, Silver JS, Deisboeck TS, Finkelstein D, Harsh GR, Louis DN, Bartus RT, Hochberg FH, Chiocca EA. Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses. Nat Med. 1999 Aug; 5(8):881-7.
    View in: PubMed
  76. Finkelstein DM, Schoenfeld DA. Combining mortality and longitudinal measures in clinical trials. Stat Med. 1999 Jun 15; 18(11):1341-54.
    View in: PubMed
  77. Shebani KO, Souba WW, Finkelstein DM, Stark PC, Elgadi KM, Tanabe KK, Ott MJ. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Ann Surg. 1999 Jun; 229(6):815-21; discussion 822-3.
    View in: PubMed
  78. Goggins WB, Finkelstein DM, Zaslavsky AM. Applying the Cox proportional hazards model when the change time of a binary time-varying covariate is interval censored. Biometrics. 1999 Jun; 55(2):445-51.
    View in: PubMed
  79. Duska LR, Penson R, Supko JG, Finkelstein DM, Makastorsis T, Gallagher J, Borden K, Goodman A, Fuller AF, Nikrui N, Seiden MV. A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer. Clin Cancer Res. 1999 Jun; 5(6):1299-305.
    View in: PubMed
  80. Ott MJ, Tanabe KK, Gadd MA, Stark P, Smith BL, Finkelstein DM, Souba WW. Multimodality management of Merkel cell carcinoma. Arch Surg. 1999 Apr; 134(4):388-92; discussion 392-3.
    View in: PubMed
  81. Debus J, Hug EB, Liebsch NJ, O'Farrel D, Finkelstein D, Efird J, Munzenrider JE. Dose-volume tolerance of the brainstem after high-dose radiotherapy. Front Radiat Ther Oncol. 1999; 33:305-14.
    View in: PubMed
  82. Goggins WB, Finkelstein DM, Schoenfeld DA, Zaslavsky AM. A Markov chain Monte Carlo EM algorithm for analyzing interval-censored data under the Cox proportional hazards model. Biometrics. 1998 Dec; 54(4):1498-507.
    View in: PubMed
  83. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst. 1998 Oct 7; 90(19):1473-9.
    View in: PubMed
  84. Cariappa A, Sands B, Forcione D, Finkelstein D, Podolsky DK, Pillai S. Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease. Gut. 1998 Aug; 43(2):210-5.
    View in: PubMed
  85. Herrlinger U, Kramm CM, Aboody-Guterman KS, Silver JS, Ikeda K, Johnston KM, Pechan PA, Barth RF, Finkelstein D, Chiocca EA, Louis DN, Breakefield XO. Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector. Gene Ther. 1998 Jun; 5(6):809-19.
    View in: PubMed
  86. Cooney MJ, Fekrat S, Finkelstein D. Current concepts in the management of central retinal vein occlusion. Curr Opin Ophthalmol. 1998 Jun; 9(3):47-50.
    View in: PubMed
  87. Colby C, McAfee SL, Finkelstein DM, Spitzer TR. Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1998 May; 21(10):1005-10.
    View in: PubMed
  88. Santoni R, Liebsch N, Finkelstein DM, Hug E, Hanssens P, Goitein M, Smith AR, O'Farrell D, Efird JT, Fullerton B, Munzenrider JE. Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull. Int J Radiat Oncol Biol Phys. 1998 Apr 1; 41(1):59-68.
    View in: PubMed
  89. Fekrat S, Goldberg MF, Finkelstein D. Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion. Arch Ophthalmol. 1998 Jan; 116(1):43-52.
    View in: PubMed
  90. Agard E, Finkelstein D, Wallach E. Cultural diversity and informed consent. J Clin Ethics. 1998; 9(2):173-6.
    View in: PubMed
  91. Debus J, Hug EB, Liebsch NJ, O'Farrel D, Finkelstein D, Efird J, Munzenrider JE. Brainstem tolerance to conformal radiotherapy of skull base tumors. Int J Radiat Oncol Biol Phys. 1997 Dec 1; 39(5):967-75.
    View in: PubMed
  92. Herrlinger U, Kramm CM, Johnston KM, Louis DN, Finkelstein D, Reznikoff G, Dranoff G, Breakefield XO, Yu JS. Vaccination for experimental gliomas using GM-CSF-transduced glioma cells. Cancer Gene Ther. 1997 Nov-Dec; 4(6):345-52.
    View in: PubMed
  93. Krainer M, Silva-Arrieta S, FitzGerald MG, Shimada A, Ishioka C, Kanamaru R, MacDonald DJ, Unsal H, Finkelstein DM, Bowcock A, Isselbacher KJ, Haber DA. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N Engl J Med. 1997 May 15; 336(20):1416-21.
    View in: PubMed
  94. Finkelstein DM, Schoenfeld DA, Stamenovic E. Analysis of multiple failure time data from an AIDS clinical trial. Stat Med. 1997 Apr 30; 16(8):951-61.
    View in: PubMed
  95. Aisenberg AC, Finkelstein DM, Doppke KP, Koerner FC, Boivin JF, Willett CG. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer. 1997 Mar 15; 79(6):1203-10.
    View in: PubMed
  96. FitzGerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ, Haber DA. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet. 1997 Mar; 15(3):307-10.
    View in: PubMed
  97. Anderson B, Ho J, Brackett J, Finkelstein D, Laffel L. Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. J Pediatr. 1997 Feb; 130(2):257-65.
    View in: PubMed
  98. Finkelstein D, Wu AW, Holtzman NA, Smith MK. When a physician harms a patient by a medical error: ethical, legal, and risk-management considerations. J Clin Ethics. 1997; 8(4):330-5.
    View in: PubMed
  99. Kim L, Hochberg FH, Thornton AF, Harsh GR, Patel H, Finkelstein D, Louis DN. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas. J Neurosurg. 1996 Oct; 85(4):602-7.
    View in: PubMed
  100. FitzGerald MG, Harkin DP, Silva-Arrieta S, MacDonald DJ, Lucchina LC, Unsal H, O'Neill E, Koh J, Finkelstein DM, Isselbacher KJ, Sober AJ, Haber DA. Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. Proc Natl Acad Sci U S A. 1996 Aug 6; 93(16):8541-5.
    View in: PubMed
  101. Homer CJ, Szilagyi P, Rodewald L, Bloom SR, Greenspan P, Yazdgerdi S, Leventhal JM, Finkelstein D, Perrin JM. Does quality of care affect rates of hospitalization for childhood asthma? Pediatrics. 1996 Jul; 98(1):18-23.
    View in: PubMed
  102. Finkelstein D. Laser therapy for central retinal vein obstruction. Curr Opin Ophthalmol. 1996 Jun; 7(3):80-3.
    View in: PubMed
  103. Finkelstein DM, Williams PL, Molenberghs G, Feinberg J, Powderly WG, Kahn J, Dolin R, Cotton D. Patterns of opportunistic infections in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 May 1; 12(1):38-45.
    View in: PubMed
  104. Perrin JM, Greenspan P, Bloom SR, Finkelstein D, Yazdgerdi S, Leventhal JM, Rodewald L, Szilagyi P, Homer CJ. Primary care involvement among hospitalized children. Arch Pediatr Adolesc Med. 1996 May; 150(5):479-86.
    View in: PubMed
  105. Safrin S, Finkelstein DM, Feinberg J, Frame P, Simpson G, Wu A, Cheung T, Soeiro R, Hojczyk P, Black JR. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group. Ann Intern Med. 1996 May 1; 124(9):792-802.
    View in: PubMed
  106. FitzGerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber JE, Duda RB, Mayzel KA, Isselbacher KJ, Friend SH, Haber DA. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med. 1996 Jan 18; 334(3):143-9.
    View in: PubMed
  107. Kempster RC, Green WR, Finkelstein D. Choroidal rupture. Clinicopathologic correlation of an unusual case. Retina. 1996; 16(1):57-63.
    View in: PubMed
  108. Ettinger DS, Finkelstein DM, Sarma RP, Johnson DH. Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol. 1995 Jun; 13(6):1430-5.
    View in: PubMed
  109. Bozzette SA, Finkelstein DM, Spector SA, Frame P, Powderly WG, He W, Phillips L, Craven D, van der Horst C, Feinberg J. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med. 1995 Mar 16; 332(11):693-9.
    View in: PubMed
  110. Powderly WG, Finkelstein D, Feinberg J, Frame P, He W, van der Horst C, Koletar SL, Eyster ME, Carey J, Waskin H, et al. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med. 1995 Mar 16; 332(11):700-5.
    View in: PubMed
  111. Draelos MT, Jacobson AM, Weinger K, Widom B, Ryan CM, Finkelstein DM, Simonson DC. Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia. Am J Med. 1995 Feb; 98(2):135-44.
    View in: PubMed
  112. Weinger K, Jacobson AM, Draelos MT, Finkelstein DM, Simonson DC. Blood glucose estimation and symptoms during hyperglycemia and hypoglycemia in patients with insulin-dependent diabetes mellitus. Am J Med. 1995 Jan; 98(1):22-31.
    View in: PubMed
  113. Finkelstein DM, Schoenfeld DA. Analysing survival in the presence of an auxiliary variable. Stat Med. 1994 Sep 15; 13(17):1747-54.
    View in: PubMed
  114. Bonomi P, Finkelstein D, Chang A. Phase II trial of acivicin versus etoposide-cisplatin in non-small cell lung cancer. An Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1994 Jun; 17(3):215-7.
    View in: PubMed
  115. Holroyd S, Rabins PV, Finkelstein D, Lavrisha M. Visual hallucinations in patients from an ophthalmology clinic and medical clinic population. J Nerv Ment Dis. 1994 May; 182(5):273-6.
    View in: PubMed
  116. Finkelstein D. Laser treatment of macular edema resulting from branch vein occlusion. Semin Ophthalmol. 1994 Mar; 9(1):23-8.
    View in: PubMed
  117. Locke SE, Kowaloff HB, Hoff RG, Safran C, Popovsky MA, Cotton DJ, Finkelstein DM, Page PL, Slack WV. Computer interview for screening blood donors for risk of HIV transmission. MD Comput. 1994 Jan-Feb; 11(1):26-32.
    View in: PubMed
  118. Powell AC, Fuchs T, Finkelstein DM, Garan H, Cannom DS, McGovern BA, Kelly E, Vlahakes GJ, Torchiana DF, Ruskin JN. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation. 1993 Sep; 88(3):1083-92.
    View in: PubMed
  119. Finkelstein DM, Moore DF, Schoenfeld DA. A proportional hazards model for truncated AIDS data. Biometrics. 1993 Sep; 49(3):731-40.
    View in: PubMed
  120. Bonomi PD, Finkelstein D, Aisner S, Ettinger D. EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma. Am J Clin Oncol. 1993 Aug; 16(4):342-5.
    View in: PubMed
  121. Schoenfeld DA, Finkelstein DM, Richman DD. Designing phase II studies of chemotherapy for HIV infection using CD4 as an end-point. AIDS. 1993 Jul; 7(7):955-8.
    View in: PubMed
  122. Cotton DJ, Powderly WG, Feinberg J, Abrams DI, Chaisson RE, Wheat LJ, Finkelstein DM, Tallman V, Zimmer B, Berzon R, et al. Guidelines for the design and conduct of AIDS clinical trials. AIDS Clinical Trials Group. Clin Infect Dis. 1993 Jun; 16(6):816-22; discussion 823-4.
    View in: PubMed
  123. Finkelstein D, Smith MK, Faden R. Informed consent and medical ethics. Arch Ophthalmol. 1993 Mar; 111(3):324-6.
    View in: PubMed
  124. Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL, Moynihan T, Ettinger DS. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. J Clin Oncol. 1993 Mar; 11(3):561-9.
    View in: PubMed
  125. Hardy WD, Feinberg J, Finkelstein DM, Power ME, He W, Kaczka C, Frame PT, Holmes M, Waskin H, Fass RJ, et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N Engl J Med. 1992 Dec 24; 327(26):1842-8.
    View in: PubMed
  126. Finkelstein D. Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion. Arch Ophthalmol. 1992 Oct; 110(10):1427-34.
    View in: PubMed
  127. Locke SE, Kowaloff HB, Hoff RG, Safran C, Popovsky MA, Cotton DJ, Finkelstein DM, Page PL, Slack WV. Computer-based interview for screening blood donors for risk of HIV transmission. JAMA. 1992 Sep 9; 268(10):1301-5.
    View in: PubMed
  128. Ettinger DS, Finkelstein DM, Abeloff MD, Skeel RT, Stott PB, Frontiera MS, Bonomi PD. Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study. J Natl Cancer Inst. 1992 Jul 15; 84(14):1077-84.
    View in: PubMed
  129. Finkelstein DM. Modeling the effect of dose on the lifetime tumor rate from an animal carcinogenicity experiment. Biometrics. 1991 Jun; 47(2):669-80.
    View in: PubMed
  130. Garabedian HD, Gold HK, Leinbach RC, Svizzero TA, Finkelstein DM, Guerrero JL, Collen D. Bleeding time prolongation and bleeding during infusion of recombinant tissue-type plasminogen activator in dogs: potentiation by aspirin and reversal with aprotinin. J Am Coll Cardiol. 1991 Apr; 17(5):1213-22.
    View in: PubMed
  131. Kinney HC, Brody BA, Finkelstein DM, Vawter GF, Mandell F, Gilles FH. Delayed central nervous system myelination in the sudden infant death syndrome. J Neuropathol Exp Neurol. 1991 Jan; 50(1):29-48.
    View in: PubMed
  132. Rosenbaum MS, Wilber DJ, Finkelstein D, Ruskin JN, Garan H. Immediate reproducibility of electrically induced sustained monomorphic ventricular tachycardia before and during antiarrhythmic therapy. J Am Coll Cardiol. 1991 Jan; 17(1):133-8.
    View in: PubMed
  133. Byar DP, Schoenfeld DA, Green SB, Amato DA, Davis R, De Gruttola V, Finkelstein DM, Gatsonis C, Gelber RD, Lagakos S, et al. Design considerations for AIDS trials. N Engl J Med. 1990 Nov 8; 323(19):1343-8.
    View in: PubMed
  134. Ettinger DS, Finkelstein DM, Abeloff MD, Chang YC, Smith TJ, Oken MM, Ruckdeschel JC. Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer. Invest New Drugs. 1990 May; 8(2):183-5.
    View in: PubMed
  135. Green SB, Ellenberg SS, Finkelstein D, Forsythe AB, Freedman LS, Freeman K, Lefkopoulou M, Schoenfeld D, Smith RP. Issues in the design of drug trials for AIDS. Control Clin Trials. 1990 Apr; 11(2):80-7.
    View in: PubMed
  136. Aisner SC, Finkelstein DM, Ettinger DS, Abeloff MD, Ruckdeschel JC, Eggleston JC. The clinical significance of variant-morphology small-cell carcinoma of the lung. J Clin Oncol. 1990 Mar; 8(3):402-8.
    View in: PubMed
  137. Ettinger DS, Finkelstein DM, Abeloff MD, Ruckdeschel JC, Aisner SC, Eggleston JC. A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group. J Clin Oncol. 1990 Feb; 8(2):230-40.
    View in: PubMed
  138. Johns JA, Leavitt MB, Newell JB, Yasuda T, Leinbach RC, Gold HK, Finkelstein D, Dinsmore RE. Quantitation of acute myocardial infarct size by nuclear magnetic resonance imaging. J Am Coll Cardiol. 1990 Jan; 15(1):143-9.
    View in: PubMed
  139. Bonomi PD, Finkelstein DM, Ruckdeschel JC, Blum RH, Green MD, Mason B, Hahn R, Tormey DC, Harris J, Comis R, et al. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. J Clin Oncol. 1989 Nov; 7(11):1602-13.
    View in: PubMed
  140. Gimple LW, Gold HK, Leinbach RC, Coller BS, Werner W, Yasuda T, Johns JA, Ziskind AA, Finkelstein D, Collen D. Correlation between template bleeding times and spontaneous bleeding during treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator. Circulation. 1989 Sep; 80(3):581-8.
    View in: PubMed
  141. Kuchar DL, Garan H, Venditti FJ, Finkelstein D, Rottman JN, McComb J, McGovern BA, Ruskin JN. Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts. Am J Cardiol. 1989 Jul 1; 64(1):33-6.
    View in: PubMed
  142. Finkelstein DM, Schoenfeld DA. Analysis of multiple tumor data from a rodent carcinogenicity experiment. Biometrics. 1989 Mar; 45(1):219-30.
    View in: PubMed
  143. Ettinger DS, Finkelstein DM, Donehower RC, Chang AY, Green M, Blum R, Hahn RG, Ruckdeschel JC. Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): an Eastern Cooperative Oncology Group study. Med Pediatr Oncol. 1989; 17(3):197-201.
    View in: PubMed
  144. Finkelstein DM, Cassileth BR, Bonomi PD, Ruckdeschel JC, Ezdinli EZ, Wolter JM. A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1988 Dec; 11(6):630-3.
    View in: PubMed
  145. Johns JA, Gold HK, Leinbach RC, Yasuda T, Gimple LW, Werner W, Finkelstein D, Newell J, Ziskind AA, Collen D. Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen activator. Circulation. 1988 Sep; 78(3):546-56.
    View in: PubMed
  146. Kelly PA, Cannom DS, Garan H, Finkelstein D, McComb JM, Mirabal GS, Ilvento JP, Ruskin JN. Predictors of automatic implantable cardioverter defibrillator discharge for life-threatening ventricular arrhythmias. Am J Cardiol. 1988 Jul 1; 62(1):83-7.
    View in: PubMed
  147. Kaul S, Finkelstein DM, Homma S, Leavitt M, Okada RD, Boucher CA. Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: a comparison with cardiac catheterization. J Am Coll Cardiol. 1988 Jul; 12(1):25-34.
    View in: PubMed
  148. Garan H, Kuchar D, Freeman C, Finkelstein D, Ruskin JN. Early assessment of the effect of map-guided transcatheter intracardiac electric shock on sustained ventricular tachycardia secondary to coronary artery disease. Am J Cardiol. 1988 May 1; 61(13):1018-23.
    View in: PubMed
  149. Garabedian HD, Gold HK, Yasuda T, Johns JA, Finkelstein DM, Gaivin RJ, Cobbaert C, Leinbach RC, Collen D. Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: correlation with acute angiography. J Am Coll Cardiol. 1988 Apr; 11(4):729-34.
    View in: PubMed
  150. Wilber DJ, Garan H, Finkelstein D, Kelly E, Newell J, McGovern B, Ruskin JN. Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med. 1988 Jan 7; 318(1):19-24.
    View in: PubMed
  151. Gill JB, Ruddy TD, Newell JB, Finkelstein DM, Strauss HW, Boucher CA. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med. 1987 Dec 10; 317(24):1486-9.
    View in: PubMed
  152. Finkelstein DM. A proportional hazards model for interval-censored failure time data. Biometrics. 1986 Dec; 42(4):845-54.
    View in: PubMed
  153. Finkelstein DM, Ettinger DS, Ruckdeschel JC. Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study. J Clin Oncol. 1986 May; 4(5):702-9.
    View in: PubMed
  154. Ruckdeschel JC, Finkelstein DM, Ettinger DS, Creech RH, Mason BA, Joss RA, Vogl S. A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer. J Clin Oncol. 1986 Jan; 4(1):14-22.
    View in: PubMed
  155. Finkelstein DM, Wolfe RA. A semiparametric model for regression analysis of interval-censored failure time data. Biometrics. 1985 Dec; 41(4):933-45.
    View in: PubMed
  156. Ettinger DS, Finkelstein DM, Harper GR, Ruckdeschel JC, Chang AY, Camacho FJ, Marsh JC, Silber R, Wolter JM. Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study. Cancer Treat Rep. 1985 Sep; 69(9):1033-4.
    View in: PubMed
  157. Abeloff MD, Finkelstein DM, Chang AY, Camacho FJ, Creech RH, Ettinger DS. Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): an Eastern Cooperative Oncology Group Study. Cancer Treat Rep. 1985 Apr; 69(4):451-2.
    View in: PubMed
  158. Ruckdeschel JC, Finkelstein DM, Mason BA, Creech RH. Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens. J Clin Oncol. 1985 Jan; 3(1):72-9.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Maria Maxell (mmaxellhsph.harvard.edu). HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Finkelstein's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
See all (689) concept(s)
_
Co-Authors
See all (132) people
_
Similar People
See all (60) people
_
Same Department
Search Department
Physical Neighbors
_